Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease
September 20th, 2018
7.3K views
Dynamic adhesion of immune cells to the vessel wall is a prerequisite for gut homing. Here, we present a protocol for a functional in vitro assay for the impact analysis of anti-integrin antibodies, chemokines or other factors on the dynamic cell adhesion of human cells using addressin-coated capillaries.
Overview
This article presents a protocol for a functional in vitro assay to analyze the dynamic adhesion of immune cells to vessel walls, crucial for gut homing. The method allows for the impact analysis of anti-integrin antibodies, chemokines, and other factors on human cell adhesion under flow conditions.
Key Study Components
Area of Science
- Immunobiology
- Inflammatory bowel disease research
- Cell adhesion mechanisms
Background
- Dynamic adhesion is essential for immune cell homing.
- This method addresses key questions in immunobiology.
- It can be adapted for various inflammatory disease settings.
- Understanding the adhesion cascade is vital for therapeutic strategies.
Purpose of Study
- To explore the effects of anti-integrin antibodies on cell adhesion.
- To provide a straightforward approach for functional analysis.
- To facilitate research on immune cell behavior under flow conditions.
Methods Used
- Stretching rubber tubing for capillary insertion.
- Coating capillaries with addressins.
- Incubation at 37 degrees Celsius.
- Sealing connections with paraffin film.
Main Results
- The method effectively analyzes cell adhesion dynamics.
- It provides insights into the role of chemokines and antibodies.
- Results can inform therapeutic approaches for inflammatory diseases.
Conclusions
- This technique is a valuable tool for immunobiology research.
- It can be modified for various inflammatory conditions.
- Understanding adhesion mechanisms can lead to better treatments.
Frequently Asked Questions
What is the significance of cell adhesion in immune response?
Cell adhesion is crucial for immune cells to migrate to sites of inflammation and perform their functions.
How can this method be adapted for other diseases?
The protocol can be modified to study adhesion in various inflammatory conditions beyond inflammatory bowel disease.
What are addressins and their role in this study?
Addressins are molecules that facilitate the adhesion of immune cells to the vascular endothelium, critical for homing.
What temperature is required for the incubation of coated capillaries?
The coated capillaries should be incubated at 37 degrees Celsius for optimal results.
Can this method be used for other types of immune cells?
Yes, the method can be adapted to study various immune cell types and their adhesion properties.
What is the main advantage of this adhesion assay?
The main advantage is its convenience and ability to answer functional questions regarding cell adhesion under flow conditions.
Executive Industry Relevance
Functional analysis of immune cell adhesion under flow conditions is critical for evaluating anti-adhesion therapies in inflammatory bowel disease. This dynamic adhesion assay provides a physiologically relevant system to assess target engagement and mechanism of action for integrin inhibitors. It supports early-stage de-risking by enabling quantitative comparison of therapeutic candidates before in vivo testing.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of integrin-dependent adhesion mechanisms under shear stress to validate target relevance in IBD pathogenesis.
- Operational Value: Provides a reproducible readout for functional screening of anti-integrin antibodies like vedolizumab and emerging candidates.
- Predictive Value: Supports mechanistic de-risking by linking antibody treatment to reduced adhesion under defined flow conditions.
Screening & Assay Development
- Scientific Value: Generates quantitative adhesion metrics by comparing cell counts before and after perfusion through addressin-coated capillaries.
- Operational Value: Uses standardized perfusion parameters (10 µL/min flow rate, 3-minute capture) to ensure reproducible dynamic adhesion measurements.
- Assay Readiness: Compatible with multiplexing via competitive adhesion assays using differentially labeled cell types to compare therapeutic effects.
Translational & Preclinical Research
- Scientific Value: Models human immune cell homing dynamics using primary PBMCs and physiologically relevant addressins (ICAM-1, VCAM-1, MAdCAM-1).
- Translational Continuity: Bridges in vitro target modulation with ex vivo functional outcomes predictive of tissue-specific immune cell recruitment.
- Preclinical Utility: Enables dose-response analysis of neutralizing antibodies to inform lead optimization and biomarker strategy.
Pipeline & Workflow Integration
The assay fits within the discovery continuum from target validation through lead identification, providing functional adhesion data that informs go/no-go decisions for anti-adhesion candidates.
- Discovery Biology: Supports hypothesis testing of integrin blockade effects on cell adhesion under flow, clarifying mechanism of action for therapeutic antibodies.
- Screening: Delivers quantitative, perfusion-based adhesion outputs that enable comparison across antibody candidates and chemokine-modulated conditions.
- Analytics: Employs time-lapse imaging and cell counting to generate subtractive adhesion scores (ending minus starting cell count) as a functional endpoint.
- Translational Research: Uses human PBMCs and disease-relevant addressins to enhance predictive confidence for IBD-specific immune cell trafficking.
- Enterprise Reuse: Adaptable to other inflammatory disease models and cell types, supporting platform reuse across immunology portfolios.
Operational & Enterprise Impact
- Scientific Value: Reduces mechanistic ambiguity in anti-integrin antibody function by providing direct, real-time visualization of adhesion inhibition.
- Operational Value: Standardizes sample preparation, perfusion, and imaging steps to improve reproducibility across laboratories and projects.
- Strategic Value: Enables earlier, more confident go/no-go decisions by validating functional target engagement before costly in vivo studies.
- Portfolio Impact: Supports risk-adjusted prioritization of adhesion-modulating therapeutics based on quantitative, mechanism-linked functional data.
Implementation Considerations
- Requires expertise in cell isolation, perfusion microscopy, and time-lapse image analysis for accurate adhesion quantification.
- Depends on specialized instrumentation including microscopes with flow chambers, peristaltic pumps, and environmental control at 37°C.
- Necessitates standardization of addressin coating, blocking, and perfusion protocols to minimize variability in adhesion readouts.
- Must account for physiological complexity limitations; the assay simplifies in vivo adhesion cascades and may not capture all contributing factors.
- Adaptation to alternative cell types or addressins requires re-optimization of cell concentration, flow rates, and incubation times.
Biopharma FAQs
Why does measuring dynamic adhesion under flow matter for target validation in IBD?
Measuring adhesion under shear stress better reflects the physiological conditions of immune cell homing in inflamed vasculature, where integrin-mediated interactions must withstand blood flow. This approach increases predictive confidence by showing whether anti-integrin antibodies can functionally inhibit adhesion in a clinically relevant context. It helps de-risk targets by confirming mechanism of action before advancing candidates to in vivo models.
How does isolating the independent variable (antibody treatment) improve discovery pipeline efficiency?
By perfusing cells pre-treated with specific anti-integrin antibodies or isotype controls, the assay isolates the effect of the antibody on adhesion, minimizing confounding variables. This enables clear attribution of reduced adhesion to target engagement rather than nonspecific effects. Such isolation supports reliable structure-activity relationship screening and lead optimization in early discovery.
What do quantitative dependent variable measurements (cell count changes) enable in therapeutic screening?
The assay quantifies adhesion by subtracting the number of white cells in the initial image from the final image after perfusion, providing a numerical readout of dynamic adhesion. This metric allows direct comparison across conditions, such as antibody-treated versus untreated cells, or different addressin coatings. Quantitative outputs support hit selection, potency ranking, and structure-function correlation in antibody screening campaigns.
Why are replication requirements important for cross-functional collaboration in assay adoption?
The protocol specifies standardized steps—such as 1-hour coating and blocking at 37°C, 10 µL/min flow rate, and 3-minute image capture—to ensure reproducibility across users and laboratories. Consistent execution allows discovery, preclinical, and translational teams to generate comparable data, reducing variability in decision-making. Reproducibility builds confidence in assay transferability and supports multi-site validation of therapeutic candidates.
What statistical analysis capabilities are required before implementing this assay in a screening cascade?
Implementing the assay requires basic statistical comparison of adhesion scores between experimental and control groups, such as isotype-treated cells, to determine significant inhibition. Data normality and variance should be assessed to choose appropriate parametric or non-parametric tests for comparing multiple antibody doses or cell types. These analyses enable objective evaluation of therapeutic effects and support go/no-go criteria in lead identification stages.
